Wealthspire Advisors LLC Has $898,000 Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Wealthspire Advisors LLC reduced its holdings in Teleflex Incorporated (NYSE:TFX) by 16.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 5,048 shares of the medical technology company’s stock after selling 1,004 shares during the quarter. Wealthspire Advisors LLC’s holdings in Teleflex were worth $898,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the business. Avior Wealth Management LLC lifted its stake in shares of Teleflex by 190.6% in the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after acquiring an additional 101 shares during the period. Ashton Thomas Securities LLC bought a new position in Teleflex during the 3rd quarter worth approximately $40,000. True Wealth Design LLC lifted its position in shares of Teleflex by 16,600.0% in the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after purchasing an additional 166 shares during the period. Capital Performance Advisors LLP bought a new stake in shares of Teleflex in the 3rd quarter valued at $54,000. Finally, Banque Cantonale Vaudoise boosted its stake in shares of Teleflex by 184.8% in the 3rd quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company’s stock valued at $56,000 after purchasing an additional 146 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Performance

Shares of TFX opened at $177.78 on Wednesday. Teleflex Incorporated has a one year low of $165.62 and a one year high of $249.90. The company has a market cap of $8.26 billion, a PE ratio of 35.34, a P/E/G ratio of 1.73 and a beta of 1.16. The stock has a 50-day moving average of $176.97 and a 200-day moving average of $206.37. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Analyst Ratings Changes

Several research firms recently issued reports on TFX. Mizuho dropped their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Royal Bank of Canada dropped their price objective on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Finally, Truist Financial dropped their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, Teleflex presently has an average rating of “Moderate Buy” and an average target price of $246.00.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.